Solius

Solius operates at the intersection of digital health, metabolic health, and medical devices, offering a novel phototherapy platform. The company's core proposition is that controlled, specific-wavelength light can safely trigger the body's natural production of vitamin D, positioning it as a potential alternative to supplements and sun exposure for addressing widespread vitamin D deficiency. While its devices appear to be commercialized, the company's go-to-market strategy and clinical validation efforts are focused on building a body of research linking vitamin D to a broad range of health conditions. Solius represents a specialized play in the growing light therapy and wellness technology market.

Proprietary medical light therapy devices that emit a specific spectrum of UVB light designed to mimic the sun's action spectrum for stimulating endogenous vitamin D production in the skin.

Solius competes with inexpensive oral vitamin D supplements, general sunlight exposure recommendations, and other medical phototherapy devices used for specific conditions like psoriasis. Its differentiation is based on its specific wavelength technology, prescription-grade status, and focus on systemic vitamin D production rather than superficial skin treatment.